This inventor holds 1 USPTO granted patent. Top assignee: The University of Tennessee Research Foundation. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: James W. Lederer: Innovator in Vaccine Development
Introduction
James W. Lederer is a notable inventor based in Advance, NC (US). He has made significant contributions to the field of vaccine development, particularly in combating streptococcal infections. His innovative work has the potential to impact public health positively.
Latest Patents
James W. Lederer holds 1 patent for a recombinant multivalent M protein vaccine. This vaccine is designed to provide protection against multiple serotypes of group A streptococci, which can lead to rheumatic fever. The vaccine not only targets these bacteria but also stimulates the production of protective mucosal antibodies. It incorporates DNA sequences that encode the necessary amino acids to produce the desired epitopes, showcasing a sophisticated approach to vaccination.
Career Highlights
Lederer is affiliated with the University of Tennessee Research Foundation, where he continues to advance his research in vaccine technology. His work is characterized by a commitment to developing effective solutions for infectious diseases.
Collaborations
One of his notable collaborators is James B. Dale, with whom he has worked on various research initiatives. Their combined expertise enhances the potential for groundbreaking advancements in the field of immunology.
Conclusion
James W. Lederer is a dedicated inventor whose work in vaccine development exemplifies innovation in addressing public health challenges. His contributions are vital in the ongoing fight against infectious diseases.